Form 4: Edgewell CFO Reports Equity Vesting and New Grant

Edgewell Personal Care CFO Francesca Weissman reported the vesting of performance stock and a new grant of restricted stock equivalents.

Summary

• Francesca Weissman, CFO of Edgewell Personal Care Co (EPC), reported transactions related to her equity compensation.
• On November 13, 2025, 2,754 Performance Stock Equivalents (PSEs) vested and converted into shares of EPC common stock. The original award was for 3,900 shares, meaning 1,146 shares did not vest due to performance criteria.
• Concurrently, 958 shares of common stock were disposed of at a price of $18.39 per share to cover tax liabilities associated with the vesting of the PSEs.
• Following these transactions, direct beneficial ownership of common stock was 27,536 shares.
• On November 14, 2025, Ms. Weissman was granted 26,476 Restricted Stock Equivalents (RSEs).
• These RSEs will vest in three equal installments on November 14, 2026, November 14, 2027, and November 14, 2028, contingent on continued employment or specific termination events.

Sentiment

Score: 7

Explanation: The filing details routine executive compensation events, including the vesting of performance awards and a new grant of restricted stock. This indicates ongoing alignment of executive interests with shareholder value and is generally a neutral to slightly positive signal, reflecting standard corporate governance practices.

Positives

• The vesting of 2,754 performance stock equivalents indicates that performance criteria were met, leading to the issuance of common stock to the CFO.
• The grant of 26,476 new Restricted Stock Equivalents demonstrates continued long-term incentive alignment between the CFO and shareholder interests.

Negatives

• Only 2,754 out of an original award of 3,900 performance stock equivalents vested, indicating that 1,146 shares were cancelled because performance criteria were not fully met.

Future Outlook

The grant of new Restricted Stock Equivalents with a three-year vesting schedule provides a clear long-term incentive for the CFO, aligning future compensation with company performance and continued employment.

Industry Context

These transactions represent routine executive compensation activities, common across publicly traded companies, designed to align management's interests with long-term shareholder value through equity awards.

Comparison to Industry Standards

• The structure of performance-based equity awards and restricted stock equivalents, along with tax withholding upon vesting, is a standard practice in executive compensation packages across various industries, including consumer goods.
• The partial vesting of performance stock indicates that the company's specific performance targets were met to a certain degree, a common outcome in performance-based incentive plans.

Stakeholder Impact

• Shareholders: The equity awards align the CFO's financial interests with the company's long-term performance, potentially encouraging decisions that enhance shareholder value.
• Employees: The compensation structure reflects standard practices for executive incentives, which can influence overall company culture regarding performance and rewards.

Next Steps

• One-third of the 26,476 Restricted Stock Equivalents will vest on November 14, 2026, November 14, 2027, and November 14, 2028, contingent on the Reporting Person's employment.

Key Dates

Recommendation

This Form 4 details routine executive compensation activities, including the vesting of performance stock and the grant of new restricted stock equivalents. These transactions do not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. It primarily reflects the ongoing alignment of executive incentives with shareholder interests, which is a standard practice.

Keywords

Edgewell Personal Care, EPC, Form 4, Insider Transaction, Executive Compensation, Stock Vesting, Restricted Stock Equivalents, Performance Stock Equivalents, CFO